-
Notifications
You must be signed in to change notification settings - Fork 1
/
blog.php
307 lines (227 loc) · 12.4 KB
/
blog.php
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Blogs</title>
<!-- css bootstrap -->
<link href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.2/dist/css/bootstrap.min.css" rel="stylesheet"
integrity="sha384-EVSTQN3/azprG1Anm3QDgpJLIm9Nao0Yz1ztcQTwFspd3yD65VohhpuuCOmLASjC" crossorigin="anonymous">
<!-- font awesome cdn link -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.3/css/all.min.css">
<!-- custom css file link -->
<link rel="stylesheet" href="css/style.css">
<style>
/* pricing section starts here */
/* Pricing Section Starts */
.pricing .heading h1 {
padding-top: 2rem;
padding-bottom: 2rem;
font-size: 3rem;
background-color: rgb(171, 89, 248);
}
.box-container {
display: flex;
flex-direction: row;
/* justify-content:space-between ; */
gap: 2rem;
justify-content: center;
padding-top: 0rem;
padding: 3rem;
}
.box-container .box h2 {
font-size: 1.5rem;
font-family: 'Times New Roman', Times, serif;
font-weight: 600;
}
.box-container .box {
height: 65vh;
width: 25vw;
border: 3px solid #8d4ff1;
display: flex;
border-radius: 10%;
flex-direction: column;
justify-content: center;
background-color: rgb(255, 254, 248);
}
.box-container .box:hover {
background-color: #9999FF;
}
.box .title p {
padding: 2rem;
}
@media(max-width:768px) {
.box-container {
display: flex;
flex-direction: column;
}
.box-container .box {
width: 70vw;
display: flex;
flex-direction: column;
/* justify-content: center; */
}
.box-container .box .desc ul {
padding-left: 0rem;
display: flex;
flex-direction: column;
justify-content: center;
}
.box-container .box .desc ul li {
/* display: none; */
font-size: 10px;
}
.box-container .box .desc ul li span {
font-size: 12px;
}
.price span {
font-size: 30px;
}
.price span i {
font-size: 1x;
}
.box-container .box .desc .btn {
width: 30%;
background-color: #8d4ff1;
font-weight: bold;
transition: 1s linear;
font-size: 1rem;
margin-bottom: 2rem;
margin-left: 6.5rem;
}
.pricing h1 {
margin-top: 6rem;
}
}
</style>
</head>
<body>
<!-- header section starts -->
<header class="fixed-top py-3">
<div class="container d-flex align-items-center justify-content-between">
<center>
<a href="index.php" class="logo"><span class="fas fa-home"></span>Clinic</a> <br>
</center>
</div>
</header>
<!-- header section end-->
<br><br><br><br>
<div class="box-container">
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Meera Roy</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Jay Raj</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Jay Raj</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
</div>
<div class="box-container">
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Meera Roy</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a></p>
</div>
</div>
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Jay Raj</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Jay Raj</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
</div>
<div class="box-container">
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Meera Roy</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a></p>
</div>
</div>
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Jay Raj</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
<div class="box">
<div class="title">
<h2 class="text-center">Dr. Jay Raj</h2>
<p>This blog was originally published on the MTaPS website by Dr. Meera Roy, Senior
Gender Advisor for the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS)
ProgramMonitoring patients who are taking a new medicine, including vaccines, is critical for
patient safety. This type of monitoring, also known as pharmacovigilance (PV), helps detect,
assess, understand, and prevent adverse effects of a medicine-related problem. PV is critical
for determining the true safety and efficacy of a product, including identification of good and
bad effects.<a href="" class="link-btn">read more</a> </p>
</div>
</div>
</div>
</section>
<!-- pricing section ends -->
</body>
</html>